Physician profile
Bridgette Runnels
NPI 1467840736
$1,850.28
in general payments reported to CMS, 2019-2025
16 companies · $661 in 2025
The $661 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $200 · 2023: $249 · 2024: $521 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $573.81 | 2021-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $282.20 | 2021-2025 | General - Therapies |
| Collegium Pharmaceutical, INC. | $190.95 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $170.72 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Valinor Pharma, LLC | $103.26 | 2023-2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.90 | 2022-2024 | Relistor |
| Pfizer INC. | $81.55 | 2024 | |
| Averitas Pharma INC. | $80.57 | 2023-2024 | Qutenza |
| Idorsia Pharmaceuticals US INC | $69.49 | 2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $55.01 | 2024-2025 | |
| Nalu Medical, INC. | $40.86 | 2021-2022 | |
| Si-Bone, INC. | $32.40 | 2025 | |
| Alexion Pharmaceuticals, INC. | $27.46 | 2025 | Ultomiris |
| Spinal Simplicity, LLC | $15.38 | 2024 | Ha Minuteman G3-R |
| Grt US Holding, INC. | $14.85 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $13.87 | 2024 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Runnels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.